Given that CD248 ligands are collagen type I, IV and fibronectin, we hypothesise that CD248 signalling represents a novel matrix-fibroblast interaction that may be a potential therapeutic target in IPF. The gene discussed is FN1; the disease is idiopathic pulmonary fibrosis.